Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2012 (2012), Article ID 573528, 8 pages
http://dx.doi.org/10.1155/2012/573528
Review Article

Immunosuppressive Exosomes: A New Approach for Treating Arthritis

Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15219, USA

Received 4 October 2011; Accepted 16 December 2011

Academic Editor: Simone Appenzeller

Copyright © 2012 Chenjie Yang and Paul D. Robbins. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. H. Evans, S. C. Ghivizzani, and P. D. Robbins, “Gene therapy of the rheumatic diseases: 1998 to 2008,” Arthritis Research and Therapy, vol. 11, no. 1, p. 209, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. P. D. Robbins, C. H. Evans, and Y. Chernajovsky, “Gene therapy for arthritis,” Gene Therapy, vol. 10, no. 10, pp. 902–911, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. J. D. Mountz, J. Chen, and H. C. Hsu, “Rheumatoid arthritis: safe and sound,” Gene Therapy, vol. 12, pp. 1542–1543, 2005. View at Publisher · View at Google Scholar
  4. R. S. Traister and R. Hirsch, “Gene therapy for arthritis,” Modern Rheumatology, vol. 18, no. 1, pp. 2–14, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. T. Tomita, E. Takeuchi, N. Tomita et al., “Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor κB decoy oligodeoxynucleotides as a gene therapy,” Arthritis and Rheumatism, vol. 42, no. 12, pp. 2532–2542, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Rutkauskaite, W. Zacharias, J. Schedel et al., “Ribozymes That Inhibit the Production of Matrix Metalloproteinase 1 Reduce the Invasiveness of Rheumatoid Arthritis Synovial Fibroblasts,” Arthritis and Rheumatism, vol. 50, no. 5, pp. 1448–1456, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. E. Rutkauskaite, D. Volkmer, Y. Shigeyama et al., “Retroviral gene transfer of an antisense construct against membrane type 1 matrix metalloproteinase reduces the invasiveness of rheumatoid arthritis synovial fibroblasts,” Arthritis and Rheumatism, vol. 52, no. 7, pp. 2010–2014, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. S. E. Raper, N. Chirmule, F. S. Lee et al., “Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer,” Molecular Genetics and Metabolism, vol. 80, no. 1-2, pp. 148–158, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Hacein-Bey-Abina, C. Von Kalle, M. Schmidt et al., “LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1,” Science, vol. 302, no. 5644, pp. 415–419, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. S. H. Kim, E. R. Lechman, S. Kim, J. Nash, T. J. Oligino, and P. D. Robbins, “Ex vivo gene delivery of IL-1Ra and soluble TNF receptor confers a distal synergistic therapeutic effect in antigen-induced arthritis,” Molecular Therapy, vol. 6, no. 5, pp. 591–600, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. R. L. Smeets, F. A. J. Van de Loo, L. A. B. Joosten et al., “Effectiveness of the Soluble Form of the Interleukin-1 Receptor Accessory Protein as an Inhibitor of Interleukin-1 in Collagen-Induced Arthritis,” Arthritis and Rheumatism, vol. 48, no. 10, pp. 2949–2958, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. S. S. Makarov, J. C. Olsen, W. N. Johnston et al., “Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 1, pp. 402–406, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. C. H. Evans, P. D. Robbins, S. C. Ghivizzani et al., “Gene transfer to human joints: progress toward a gene therapy of arthritis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 24, pp. 8698–8703, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. T. Pap, R. E. Gay, U. Muller-Ladner, and S. Gay, “Ex vivo gene transfer in the years to come,” Arthritis Research, vol. 4, no. 1, pp. 10–12, 2002. View at Publisher · View at Google Scholar
  15. A. Nakajima, C. M. Seroogy, M. R. Sandora et al., “Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis,” Journal of Clinical Investigation, vol. 107, no. 10, pp. 1293–1301, 2001. View at Google Scholar · View at Scopus
  16. D. H. Munn, M. D. Sharma, J. R. Lee Jr et al., “Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase,” Science, vol. 297, no. 5588, pp. 1867–1870, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. A. Tuettenberg, E. Huter, M. Hubo et al., “The role of ICOS in directing T cell responses: ICOS-dependent induction of T cell anergy by tolerogenic dendritic cells,” Journal of Immunology, vol. 182, no. 6, pp. 3349–3356, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. S. Yamazaki, T. Iyoda, K. Tarbell et al., “Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells,” Journal of Experimental Medicine, vol. 198, no. 2, pp. 235–247, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. H. Jonuleit, E. Schmitt, G. Schuler, J. Knop, and A. H. Enk, “Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells,” Journal of Experimental Medicine, vol. 192, no. 9, pp. 1213–1222, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Sato, N. Yamashita, M. Baba, and T. Matsuyama, “Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells,” Blood, vol. 101, no. 9, pp. 3581–3589, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. K. Mahnke, E. Schmitt, L. Bonifaz, A. H. Enk, and H. Jonuleit, “Immature, but not inactive: the tolerogenic function of immature dendritic cells,” Immunology and Cell Biology, vol. 80, no. 5, pp. 477–483, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. Y. Morita, J. Yang, R. Gupta et al., “Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis,” Journal of Clinical Investigation, vol. 107, no. 10, pp. 1275–1284, 2001. View at Google Scholar · View at Scopus
  23. S. H. Kim, S. Kim, C. H. Evans, S. C. Ghivizzani, T. Oligino, and P. D. Robbins, “Effective treatment of established murine collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express IL-4,” Journal of Immunology, vol. 166, no. 5, pp. 3499–3505, 2001. View at Google Scholar · View at Scopus
  24. R. J. Creusot, S. S. Yaghoubi, K. Kodama et al., “Tissue-targeted therapy of autoimmune diabetes using dendritic cells transduced to express IL-4 in NOD mice,” Clinical Immunology, vol. 127, no. 2, pp. 176–187, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. M. Feili-Hariri, D. H. Falkner, A. Gambotto et al., “Dendritic cells transduced to express interleukin-4 prevent diabetes in nonobese diabetic mice with advanced insulitis,” Human Gene Therapy, vol. 14, no. 1, pp. 13–23, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. S. H. Kim, S. Kim, T. J. Oligino, and P. D. Robbins, “Effective treatment of established mouse collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express fasL,” Molecular Therapy, vol. 6, no. 5, pp. 584–590, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. C. H. Evans, S. C. Ghivizzani, and P. D. Robbins, “Gene therapy for arthritis: what next?” Arthritis and Rheumatism, vol. 54, no. 6, pp. 1714–1729, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. C. Théry, L. Zitvogel, and S. Amigorena, “Exosomes: composition, biogenesis and function,” Nature Reviews Immunology, vol. 2, no. 8, pp. 569–579, 2002. View at Google Scholar · View at Scopus
  29. A. E. Morelli, A. T. Larregina, W. J. Shufesky et al., “Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells,” Blood, vol. 104, no. 10, pp. 3257–3266, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. K. Denzer, M. J. Kleijmeer, H. F. G. Heijnen, W. Stoorvogel, and H. J. Geuze, “Exosome: from internal vesicle of the multivesicular body to intercellular signaling device,” Journal of Cell Science, vol. 113, no. 19, pp. 3365–3374, 2000. View at Google Scholar · View at Scopus
  31. C. Théry, M. Ostrowski, and E. Segura, “Membrane vesicles as conveyors of immune responses,” Nature Reviews Immunology, vol. 9, no. 8, pp. 581–593, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. H. Matsuo, J. Chevallier, N. Mayran et al., “Role of LBPA and Alix in Multivesicular Liposome Formation and Endosome Organization,” Science, vol. 303, no. 5657, pp. 531–534, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J. J. Lee, and J. O. Lotvall, “Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells,” Nature Cell Biology, vol. 9, no. 6, pp. 654–659, 2007. View at Publisher · View at Google Scholar · View at PubMed
  34. J. Skog, T. Würdinger, S. van Rijn et al., “Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers,” Nature Cell Biology, vol. 10, no. 12, pp. 1470–1476, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. D. D. Taylor and C. Gercel-Taylor, “MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer,” Gynecologic Oncology, vol. 110, no. 1, pp. 13–21, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. S. H. Kim, E. R. Lechman, N. Bianco et al., “Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis,” Journal of Immunology, vol. 174, no. 10, pp. 6440–6448, 2005. View at Google Scholar · View at Scopus
  37. S. H. Kim, N. R. Bianco, W. J. Shufesky, A. E. Morelli, and P. D. Robbins, “MHC class II+ exosomes in plasma suppress inflammation in an antigen-specific and Fas ligand/Fas-dependent manner,” Journal of Immunology, vol. 179, no. 4, pp. 2235–2241, 2007. View at Google Scholar · View at Scopus
  38. Y. Ma, S. Thornton, L. E. Duwel et al., “Inhibition of collagen-induced arthritis in mice by viral il-10 gene transfer,” Journal of Immunology, vol. 161, no. 3, pp. 1516–1524, 1998. View at Google Scholar · View at Scopus
  39. M. A. Ruffner, H. K. Seon, N. R. Bianco, L. M. Francisco, A. H. Sharpe, and P. D. Robbins, “B7-1/2, but not PD-L1/2 molecules, are required on IL-10-treated tolerogenic DC and DC-derived exosomes for in vivo function,” European Journal of Immunology, vol. 39, no. 11, pp. 3084–3090, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. S. H. Kim, N. R. Bianco, W. J. Shufesky, A. E. Morelli, and P. D. Robbins, “Effective treatment of inflammatory disease models with exosomes derived from dendritic cells genetically modified to express IL-4,” Journal of Immunology, vol. 179, no. 4, pp. 2242–2249, 2007. View at Google Scholar · View at Scopus
  41. W. P. Min, R. Gorczynski, X. Y. Huang et al., “Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival,” Journal of Immunology, vol. 164, no. 1, pp. 161–167, 2000. View at Google Scholar · View at Scopus
  42. S. H. Kim, N. Bianco, R. Menon et al., “Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive,” Molecular Therapy, vol. 13, no. 2, pp. 289–300, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. M. J. Martínez-Lorenzo, A. Anel, B. Saez-Gutierrez et al., “Rheumatoid synovial fluid T cells are sensitive to APO2L/TRAIL,” Clinical Immunology, vol. 122, no. 1, pp. 28–40, 2007. View at Publisher · View at Google Scholar · View at PubMed
  44. L. Martinez-Lostao, F. Garcia-Alvarez, G. Basanez et al., “Liposome-bound APO2L/TRAIL is an effective treatment in a rabbit model of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 62, no. 8, pp. 2272–2282, 2010. View at Publisher · View at Google Scholar · View at PubMed
  45. F. Fallarino, U. Grohmann, S. You et al., “The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells,” Journal of Immunology, vol. 176, no. 11, pp. 6752–6761, 2006. View at Google Scholar · View at Scopus
  46. A. Curti, S. Trabanelli, V. Salvestrini, M. Baccarani, and R. M. Lemoli, “The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology,” Blood, vol. 113, no. 11, pp. 2394–2401, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. N. R. Bianco, H. K. Seon, M. A. Ruffner, and P. D. Robbins, “Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models,” Arthritis and Rheumatism, vol. 60, no. 2, pp. 380–389, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. E. R. Lechman, D. Jaffurs, S. C. Ghivizzani et al., “Direct adenoviral gene transfer of viral IL-10 to rabbit knees with experimental arthritis ameliorates disease in both injected and contralateral control knees,” Journal of Immunology, vol. 163, no. 4, pp. 2202–2208, 1999. View at Google Scholar · View at Scopus
  49. A. C. Bakker, L. A. B. Joosten, O. J. Arntz et al., “Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee,” Arthritis and Rheumatism, vol. 40, no. 5, pp. 893–900, 1997. View at Google Scholar · View at Scopus
  50. S. C. Ghivizzani, E. R. Lechman, R. Kang et al., “Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor α soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 8, pp. 4613–4618, 1998. View at Publisher · View at Google Scholar · View at Scopus
  51. E. R. Lechman, A. Keravala, J. Nash, S. H. Kim, Z. Mi, and P. D. Robbins, “The contralateral effect conferred by intra-articular adenovirus-mediated gene transfer of viral IL-10 is specific to the immunizing antigen,” Gene Therapy, vol. 10, no. 24, pp. 2029–2035, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  52. A. Sabapatha, C. Gercel-taylor, and D. D. Taylor, “Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences,” American Journal of Reproductive Immunology, vol. 56, no. 5-6, pp. 345–355, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. M. Hedlund, A. C. Stenqvist, O. Nagaeva et al., “Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function,” Journal of Immunology, vol. 183, no. 1, pp. 340–351, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. S. Ostman, M. Taube, and E. Telemo, “Tolerosome-induced oral tolerance is MHC dependent,” Immunology, vol. 116, no. 4, pp. 464–476, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  55. N. Prado, E. G. Marazuela, E. Segura et al., “Exosomes from bronchoalveolar fluid of tolerized mice prevent allergic reaction,” Journal of Immunology, vol. 181, no. 2, pp. 1519–1525, 2008. View at Google Scholar
  56. C. Admyre, S. M. Johansson, K. R. Qazi et al., “Exosomes with immune modulatory features are present in human breast milk,” Journal of Immunology, vol. 179, no. 3, pp. 1969–1978, 2007. View at Google Scholar · View at Scopus
  57. H. Meijer, J. Reinecke, C. Becker, G. Tholen, and P. Wehling, “The production of anti-inflammatory cytokines in whole blood by physico-chemical induction,” Inflammation Research, vol. 52, no. 10, pp. 404–407, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  58. P. Wehling, C. Moser, D. Frisbied et al., “Autologous conditioned serum in the treatment of orthopedic diseases: the Orthokine® therapy,” BioDrugs, vol. 21, no. 5, pp. 323–332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. A. W. A. Baltzer, C. Moser, S. A. Jansen, and R. Krauspe, “Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis,” Osteoarthritis and Cartilage, vol. 17, no. 2, pp. 152–160, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  60. http://www.wehling-hartmann.de/en/information-for-patients/therapeutic-methods/exosomen/, 2011.
  61. H. G. Zhang, C. Liu, K. Su et al., “A membrane form of TNF-α presented by exosomes delays T cell activation-induced cell death,” Journal of Immunology, vol. 176, no. 12, pp. 7385–7393, 2006. View at Google Scholar · View at Scopus
  62. K. Skriner, K. Adolph, P. R. Jungblut, and G. R. Burmester, “Association of citrullinated proteins with synovial exosomes,” Arthritis and Rheumatism, vol. 54, no. 12, pp. 3809–3814, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. N. Mor-Vaknin, A. Punturieri, K. Sitwala et al., “The DEK nuclear autoantigen is a secreted chemotactic factor,” Molecular and Cellular Biology, vol. 26, no. 24, pp. 9484–9496, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. N. Mor-Vaknin, F. Kappes, A. E. Dick et al., “DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen,” Arthritis and Rheumatism, vol. 63, no. 2, pp. 556–567, 2011. View at Publisher · View at Google Scholar
  65. H. C. Anderson, D. Mulhall, and R. Garimella, “Role of extracellular membrane vesicles in the pathogenesis of various diseases, including cancer, renal diseases, atherosclerosis, and arthritis,” Laboratory Investigation, vol. 90, no. 11, pp. 1549–1557, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus